ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 092,11
-0,61%
Dow Jones
39 671,04
-0,51%
DAX
18 680,20
-0,25%
Brent Oil
81,27
-0,32%
Bitcoin
69 382,23
0,40%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Axogen Inc (AXGN)

  7. Axogen Inc (AXGN) Actualités

AXGN

Axogen (AXGN)

Axogen Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AXGN
DateHeureSourceTitreSymboleSociété
16/05/202413h00GlobeNewswire Inc.Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®NASDAQ:AXGNAxogen Inc
14/05/202413h00GlobeNewswire Inc.Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads ConferenceNASDAQ:AXGNAxogen Inc
02/05/202413h00GlobeNewswire Inc.Axogen, Inc Reports First Quarter 2024 Financial ResultsNASDAQ:AXGNAxogen Inc
29/04/202422h50GlobeNewswire Inc.Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™NASDAQ:AXGNAxogen Inc
16/04/202413h00GlobeNewswire Inc.Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:AXGNAxogen Inc
08/03/202423h33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
08/03/202422h38Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
08/03/202400h12Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
06/03/202414h59Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AXGNAxogen Inc
06/03/202414h53Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AXGNAxogen Inc
06/03/202414h45Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AXGNAxogen Inc
05/03/202413h00GlobeNewswire Inc.Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial ResultsNASDAQ:AXGNAxogen Inc
14/02/202421h22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
13/02/202422h30GlobeNewswire Inc.Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024NASDAQ:AXGNAxogen Inc
12/02/202419h21Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AXGNAxogen Inc
02/02/202422h15GlobeNewswire Inc.Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
18/01/202423h00GlobeNewswire Inc.Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve CapNASDAQ:AXGNAxogen Inc
11/01/202423h10Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
05/01/202423h21Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AXGNAxogen Inc
04/01/202422h45GlobeNewswire Inc.Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023NASDAQ:AXGNAxogen Inc
04/01/202422h40GlobeNewswire Inc.Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025NASDAQ:AXGNAxogen Inc
04/01/202422h35GlobeNewswire Inc.Axogen Announces Promotions on Research and Development TeamNASDAQ:AXGNAxogen Inc
26/12/202322h15GlobeNewswire Inc.Axogen, Inc. Appoints Kathy Weiler to its Board of DirectorsNASDAQ:AXGNAxogen Inc
06/12/202313h00GlobeNewswire Inc.Axogen Announces Transition of Finance Team LeadershipNASDAQ:AXGNAxogen Inc
01/12/202323h00GlobeNewswire Inc.Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AXGNAxogen Inc
20/11/202313h00GlobeNewswire Inc.Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare ConferenceNASDAQ:AXGNAxogen Inc
07/11/202322h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXGNAxogen Inc
07/11/202313h00GlobeNewswire Inc.Axogen, Inc. Reports 2023 Third Quarter Financial ResultsNASDAQ:AXGNAxogen Inc
18/10/202313h00GlobeNewswire Inc.Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023NASDAQ:AXGNAxogen Inc
05/09/202313h00GlobeNewswire Inc.Axogen, Inc. Announces Full Launch of Axoguard HA+ Nerve Protector™NASDAQ:AXGNAxogen Inc
 Showing the most relevant articles for your search:NASDAQ:AXGN

Dernières Valeurs Consultées

EU
IFMAE
IDF Mobilites Domestic b...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés